# Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel

> **NCT01539876** · PHASE1 · WITHDRAWN · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's**

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Fine needle aspiration assessing tumour TNFa levels

## Key facts

- **NCT ID:** NCT01539876
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Disease Site Team changed research focus unlikely to have sufficient support to complete study
- **Last updated:** 2014-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01539876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01539876, "Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01539876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*